CymitQuimica logo

CAS 214766-78-6

:

Degarelix acetate

Description:
Degarelix acetate is a synthetic peptide and a gonadotropin-releasing hormone (GnRH) antagonist used primarily in the treatment of prostate cancer. It functions by inhibiting the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a rapid decrease in testosterone levels. This mechanism helps to reduce the stimulation of prostate cancer cells, which often rely on testosterone for growth. Degarelix is characterized by its ability to provide a quick onset of action compared to traditional GnRH agonists, which initially increase hormone levels before causing a decline. The substance is typically administered via subcutaneous injection and is known for its relatively favorable side effect profile, although it may still cause reactions such as injection site pain, hot flashes, and weight gain. Its chemical structure includes a series of amino acids that contribute to its biological activity, and it is classified as a peptide drug. As with any medication, its use should be monitored by healthcare professionals to manage potential side effects and ensure efficacy.
Formula:C82H103ClN18O16
Synonyms:
  • Degarelix
  • Firmagon
  • D-Alaninamide,N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-ly
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.